Saccharomyces Bouladii

Indications

• Antibiotic-associated diarrhea
• Gastroenteritis
• Irritable bowel syndrome
• Inflammatory bowel disease
• Maintenance of gut microbiota balance

Dosage

Children: Refer to specific product guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to specific product guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

Bouladii exerts its effects primarily through the colonization of the intestinal tract, where it competes with pathogenic microorganisms for nutrients and adhesion sites. It produces metabolites such as lactic acid, which lowers intestinal pH, creating an environment less favorable for harmful bacteria. Additionally, bouladii is believed to enhance the intestinal barrier function and modulate the immune system by stimulating the production of immunoglobulin A (IgA) and other immune factors.

Pharmacodynamics

The pharmacodynamics of bouladii involve its ability to survive gastrointestinal transit, adhere to intestinal epithelial cells, and proliferate in the gut. This leads to an increase in beneficial gut bacteria and a decrease in the colonization of pathogens. The strain's probiotic effects can contribute to improved gut health, enhanced digestion, and a balanced immune response, potentially alleviating symptoms of gastrointestinal disorders such as diarrhea and irritable bowel syndrome.

Pharmacokinetics

Bouladii is administered orally and can survive the acidic environment of the stomach. Once it reaches the intestine, it colonizes the gut and can remain for a limited period, depending on factors such as diet and the presence of other microorganisms. The pharmacokinetics of bouladii are characterized by its ability to transiently modify gut flora, with effects that may persist for some time after discontinuation of use. However, precise pharmacokinetic parameters such as absorption and elimination half-life are not well-defined due to the nature of probiotic organisms.

Pregnancy

There is limited information on the use of bouladii during pregnancy. Consult healthcare professionals for risk assessment.

Breast-feeding

There is insufficient data on the excretion of bouladii in human milk. Exercise caution and consult a healthcare professional.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Antibiotic-associated diarrhea
• Acute infectious diarrhea
• Chronic diarrhea in conditions like irritable bowel syndrome
• Maintenance of gut flora during antibiotic therapy
• Prevention of traveler's diarrhea

Dosage

Children: Refer to specific product guidelines for paediatric dosages, as they may vary depending on the formulation and age of the child.

Adults: Refer to specific product guidelines for recommended adult dosages, as they may vary depending on the formulation.

Mechanism of action

Saccharomyces boulardii exerts its effects by promoting gut health through various mechanisms. It enhances the intestinal barrier function, modulates local immune responses, and inhibits the growth of pathogenic bacteria. It also produces short-chain fatty acids and aids in the maintenance of gut microbiota balance, which can help in reducing diarrhea and improving gut health.

Pharmacodynamics

The pharmacodynamics of Saccharomyces involve its ability to adhere to intestinal mucosa, which helps in restoring the normal flora of the gut. It has been shown to reduce the duration and severity of diarrhea, particularly in cases of antibiotic-associated diarrhea and infectious diarrhea. Additionally, it may enhance the absorption of nutrients and support the immune system.

Pharmacokinetics

Saccharomyces boulardii is generally not absorbed systemically; instead, it acts locally in the gastrointestinal tract. It survives passage through the stomach and colonizes the intestines, where it exerts its beneficial effects. The viability of Saccharomyces is influenced by factors such as pH, temperature, and the presence of other gastrointestinal microorganisms. Its effects are typically observed within a few days of administration.

Adverse effects

• Gastrointestinal upset
• Bloating
• Gas
• Diarrhea

Interactions

• May interact with antifungal medications
• Potential interactions with immunosuppressive drugs

Precautions

• Caution in patients with compromised immune systems
• Use with caution in patients with a history of yeast allergies

Pregnancy

Limited data available, consult healthcare provider before use.

Breast-feeding

Generally considered safe, but consult healthcare provider.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Capsules
• Tablets
• Powder for oral suspension
• Granules